Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension

American Journal of Hypertension

Volumn 14, Issue 6 I, 2001, Pages 546-552

  Asmar, Roland ^a   Safar, Michel ^b   Queneau, Patrice ^c  

^a L'Institut CardioVasculaire   (France)

^b HÔPITAL BROUSSAIS   (France)

^c SERVICE DE NEUROLOGIE   (France)

Author keywords

Ambulatory blood pressure monitoring; Blood pressure; Placebo; Regression to the mean; Reproducibility

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SPHYGMOMANOMETER;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE DETERMINATION; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0034986799     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)01286-3     Document Type: Article

References (23)

1. The placebo effect in cardiovascular disease
2. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension. Observations from a Department of Veterans Affairs Cooperative Study
3. Lack of placebo effect on ambulatory blood pressure
4. Effect of placebo on 24-h noninvasive ambulatory blood pressure
5. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile
6. Is placebo necessary in a clinical trial or ambulatory blood pressure?
7. Influence of observer's expectation on the placebo effect in blood pressure trials
8. The powerful placebo: Fact or fiction?
9. The powerful placebo
10. A multicenter, double-blind, randomized, placebo controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension
11. Department of veteran affairs single-drug therapy of hypertension study. Revised figures and new data
12. Losartan with hydrochlorothiazide in the treatment of hypertension
13. Placebo effect and adaptation to noninvasive monitoring of BP
14. Trough-to-peak ratio of indapamide 1.5 mg sustained-release coated tablets assessed by ambulatory blood pressure monitoring
15. Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension
16. Effect of placebo on office and on 24 hour noninvasive ambulatory blood pressure measurements
17. Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality
18. Measures of blood pressure and myocardial infarction in treated hypertensive patients
19. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function
20. Increased pulse pressure and risk of heart failure in the elderly
21. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population
22. Relationship of blood pressure to cardiovascular death: The effects of pulse pressure in the elderly
23. Ambulatory pulse pressure. A potent predictor of total cardiovascular risk in hypertension